đź’¨ Abstract
Coherus BioSciences Inc. reported a first-quarter loss of $56.6 million, or 49 cents per share. Adjusted losses were 35 cents per share. The company's revenue was $7.6 million, falling short of analysts' expectations of $52.3 million. The drug developer is based in Redwood City, California.
Courtesy: wtop.com
Summarized by Einstein Beta 🤖
Suggested
Kyohei Yamasawa sets a benchmark as the top regular season scorer in Japan Rugby League One -
Arias has 3-run double, RamĂrez steals 3 bases as Guardians blank Brewers -
Alonso pushes Mets past Pirates 4-3 after solid outing by Skenes -
JosĂ© RamĂrez moves up on Guardians stolen bases list with his 3rd career 3 steal game -
Swanson and Suzuki homer as the Cubs beat the Marlins 5-2 -
Los precios de los automĂłviles no han aumentado a pesar de los aranceles; eso no es necesariamente algo bueno -
Knicks take a 3-1 lead over the Celtics with a 121-113 victory as Tatum is injured in final minutes -
Jayson Tatum carried off floor with right leg injury late in Celtics’ loss in Game 4 to Knicks -
Winning numbers drawn in Monday’s Virginia Cash Pop -
Nikolov leads Long Beach St. to three-set sweep over UCLA to claim NCAA volleyball crown -
Powered by MessengerX.io